Characterization of SCID patients studied
| SCID type . | Number of patients . | ||||
|---|---|---|---|---|---|
| Tested for TRECs . | Positive for TRECs . | T-cell chimerism . | B-cell chimerism . | On IVIG . | |
| γc Def (N = 60) | 57 | 47 | 59 | 20 | 40 |
| ADADef (N = 18) | 13 | 11 | 11 | 10 | 6 |
| IL-7RαDef (N = 15) | 15 | 14 | 15 | 1 | 3 |
| Jak3 Def (N = 11) | 10 | 10 | 11 | 4 | 7 |
| Artemis (N = 1) | 0 | 0 | 1 | 0 | 0 |
| RAG1/2Def (N = 6) | 5 | 2 | 6 | 1 | 5 |
| Unknown (N = 1) | 1 | 1 | 1 | 1 | 0 |
| CD3 Def (N = 4) | 4 | 3 | 3 | 0 | 2 |
| CD45 Def (N = 1) | 1 | 1 | 1 | 1 | 0 |
| AutoRec (N = 11) | 9 | 4 | 10 | 3 | 7 |
| Totals (N = 128) | 115 | 93 | 118 | 41 | 70 |
| SCID type . | Number of patients . | ||||
|---|---|---|---|---|---|
| Tested for TRECs . | Positive for TRECs . | T-cell chimerism . | B-cell chimerism . | On IVIG . | |
| γc Def (N = 60) | 57 | 47 | 59 | 20 | 40 |
| ADADef (N = 18) | 13 | 11 | 11 | 10 | 6 |
| IL-7RαDef (N = 15) | 15 | 14 | 15 | 1 | 3 |
| Jak3 Def (N = 11) | 10 | 10 | 11 | 4 | 7 |
| Artemis (N = 1) | 0 | 0 | 1 | 0 | 0 |
| RAG1/2Def (N = 6) | 5 | 2 | 6 | 1 | 5 |
| Unknown (N = 1) | 1 | 1 | 1 | 1 | 0 |
| CD3 Def (N = 4) | 4 | 3 | 3 | 0 | 2 |
| CD45 Def (N = 1) | 1 | 1 | 1 | 1 | 0 |
| AutoRec (N = 11) | 9 | 4 | 10 | 3 | 7 |
| Totals (N = 128) | 115 | 93 | 118 | 41 | 70 |